⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Symclosene SCHEMBL21090 | 0.74 | — | — | |
| Symclosene SCHEMBL28935086 | 0.70 | — | — | |
| Symclosene SCHEMBL21858976 | 0.67 | — | — | |
| SCHEMBL31006320 | 0.63 | — | — | |
| SCHEMBL3292259 | 0.62 | — | — | |
| SCHEMBL31207086 | 0.56 | — | — | |
| SCHEMBL31325568 | 0.56 | — | — | |
| SCHEMBL15258899 | 0.47 | — | — | |
| SCHEMBL29525411 | 0.45 | KDM4E (0.40) | — | |
| SCHEMBL29525891 | 0.45 | KDM4E (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5043554-A | — | — | None | — | — | JP | disclosed |
| JP-5043553-A | — | — | None | — | — | JP | disclosed |
| WO-2023098650-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 盖鑫 | 2023-06-08 | — | — | WO | disclosed |
| US-20220185841-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE | FUJIFILM CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-4011902-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTING GROUP, AND HYDRAZINE DERIVATIVE | FUJIFILM Corporation (JP) | 2022-06-15 | — | — | EP | disclosed |
| WO-2021049552-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTING GROUP, AND HYDRAZINE DERIVATIVE | 富士フイルム株式会社 | 2021-03-18 | — | — | WO | disclosed |
| CN-101918398-A | 4,4-disubstituted piperidines | NOVARTIS AG | 2010-12-15 | — | — | CN | disclosed |
| EP-1019434-B1 | INHIBITORS OF METALLOPROTEINASES, THEIR THERAPEUTIC USE, AND PROCESS FOR THE PRODUCTION OF THE STARTING COMPOUND IN THEIR SYNTHESIS | POLIFARMA SPA (IT) | 2003-10-01 | — | — | EP | disclosed |
| US-6339160-B1 | FOR THERAPY OF TUMORAL GROWTH AND METASTATIZATION, ATEROSCLEROSIS, MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, OSTEOPOROSIS, HYPERTENSION, RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES | POLIFARMA S.P.A. (IT) | 2002-01-15 | — | — | US | disclosed |
| EP-1019434-A2 | INHIBITORS OF METALLOPROTEINASES, THEIR THERAPEUTIC USE, AND PROCESS FOR THE PRODUCTION OF THE STARTING COMPOUND IN THEIR SYNTHESIS | POLIFARMA S.p.A. (IT) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999003878-A2 | INHIBITORS OF METALLOPROTEINASES, THEIR THERAPEUTIC USE, AND PROCESS FOR THE PRODUCTION OF THE STARTING COMPOUND IN THEIR SYNTHESIS | POLIFARMA S.P.A. (IT) | 1999-01-28 | — | — | WO | disclosed |
| JP-H0543553-A | PRODUCTION OF 3, 5-DICHLOROPYRAZOLE-4-CARBOXYLIC ACID ESTERS | NISSAN CHEM IND LTD | 1993-02-23 | — | — | JP | disclosed |
| JP-H0543554-A | PRODUCTION OF 3, 5-DICHLOROPYRAZOLE-4-CARBOXYLIC ACID ESTERS | NISSAN CHEM IND LTD | 1993-02-23 | — | — | JP | disclosed |